Is Bristol Myers Squibb Stock a Buy?
Healthcare and pharmaceutical companies are in the spotlight right now, for obvious reasons, as the world watches to see which -- if any -- can find a cure and/or vaccine for the deadly coronavirus that has affected millions. As of July 31, the number of cases has touched the 17.3 million mark, with 674,000 deaths globally. In the U.S, the recorded cases stand at 4.5 million with 154,000 deaths.
But this isn't the only reason one should consider the pharma sector now -- especially this New York-based pharma company. Reasons for investing in Bristol Myers Squibb (NYSE: BMY) go beyond the coronavirus situation. Here's why adding this stock to your portfolio might be good for long-term growth.
Image source: Getty Images.
Source Fool.com
